← All trials
NCT03036059
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 19, 2017
- Primary completion
- Feb 1, 2020
- Completion date
- Feb 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 1440
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Noguchi Memorial Institute for Medical ResearchLead sponsor
- Noguchi Memorial Institute for Medical ResearchOverall official - principal investigator
- Ghana Health ServicesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.